Introduction
Affinity chromatography has relied historically on specific bioaffinity interactions between a resinbound ligand and its biomolecular partner to effect the separation of that partner from a complex mixture of components ( Figure 1 ). 1 For successful application, the coupled ligand must retain its specific binding affinity for the target molecule and, once the unbound material has been removed by washing, the binding between the ligand and the target molecule must be reversible to allow the target molecule to be removed in an active form. 2 Perhaps one of the most notable early examples of the use of affinity chromatography for the identification of the binding partner of small-molecules was the capture of the rapamycin-and FK506-binding protein (FKBP) and other immunophilins from a human Jurkat T cell line extract. 3 More recently, affinity chromatography has been applied to the field of proteomics either in combination with small molecule probes for activity-based protein profiling to generate specific sub-proteomes, 4 or through amino-acid specific labelling of proteins (e.g. with biotin). This can be done either prior to, or post, trypsin digest to allow pre-fractionation of a complex mixture of peptides through an intermediate purification protocol (e.g. on streptavidin-coated beads) before MS analysis. 5, 6 However, the efficient recovery of the separated biomaterial in a functionally active form can be a difficult process since it often requires elution using high salt concentrations and/or detergents [ Figure 1 (a)]. 2 For this reason, general elution methods which are independent of the bioaffinity interaction (so-called affinity-independent elution protocols) are of particular interest. 10 and in the functionalisation of a tyrosine residue on the surface of viral capsids. 11 Thus in designing a cleavable support for affinity-independent elution methodology that was compatible with the extensive range of propargyl functionalised "click"
ligands that have emerged in recent years, 12, 13 we chose to base our linker on this precedent.
Results and discussion
Azobenzene linker 1 was designed with orthogonal reactive functionalities: an amine for linking to a matrix support, and an azide for reaction with the propargyl-functionalised ligands of interest. The azobenzene unit (2) at the heart of this linker was found to be readily accessible through diazotisation of 4-aminobenzoic acid and reaction with phenol (Scheme 1).
14 Etherification of the phenol in the presence of the benzoic acid was found to give a mixture of products, but reaction of the acid with N-Boc-ethylenediamine 15 In order to test how robust the new linker would be in an affinity-independent elution protocol, the biotin/(strept)avidin affinity pair was selected. Biotin and its affinity partner (strept)avidin exhibit one of the strongest known non-covalent interactions with a dissociation constant of K D ≈ 10 -15 M and they are widely used in affinity based separations. 19 Although direct attachment of biotin to the matrix and isolation of its known binding partner, avidin, was chosen to investi gate the new click linker properties (Figure 1b , "unknown" target = avidin), this study would also probe the ability of the linker to provide an affinity-independent elution protocol where a click functionalised ligand was coupled to a biotinylated derivative of linker and a (strept)avidincoated matrix used to isolate the unknown target of the ligand following incubation (Figure 1c ). The propargyl amide derivative of biotin 21 was coupled directly to the azido matrix 5 to generate affinity matrix 9, as well as through the cleavable azobenzene unit in 6 to generate affinity matrix 10 (Scheme 3). In the first set of affinity experiments designed to test the new linker for its ability to bind the affinity partner without any competing non-specific interactions, both matrices 9 and 10 were incubated with avidin, whilst only matrix 10 with its novel azo "click" linker was incubated with albumin (negative control). The absence of a clear band for avidin (15 kDa) in the supernatant following incubation shows that both matrices bound avidin (Figure 2, lanes A linker has been demonstrated using the agarose matrix Affi-Gel 10, we believe that it will find widespread application on a range of activated matrix and/or chip surfaces. It is anticipated that the use of this azo linker as means of coupling biotin to the ligand of interest will also allow an affinity-independent version of the more classical manifold for target identification based upon immobilisation on a (strept)avidin coated matrix, as well as allowing in vivo experiments.
Investigations with several ligands of interest (whose propargyl derivatives retain the activity of the lead compound) with known, or potential, affinity partners are currently under progress in our research group.
